뇌심부 자극 기기 시장 규모는 2023년에 14억 6,000만 달러로 평가되었고, 2026-2032년 연평균 9.20% 성장하여 2032년에는 27억 7,000만 달러에 달할 것으로 예측됩니다.
뇌심부자극장치(DBS)는 이식된 전극을 통해 뇌의 특정 부위에 전기 자극을 보내는 의료기기입니다. 이 장치는 펄스 발생기와 연동되어 있으며, 일반적으로 가슴의 피하에 삽입되며, DBS는 일반적으로 다양한 신경 질환의 치료 효과가 있는 비정상적인 뇌 활동을 제어하는 데 사용됩니다.
DBS는 일반적으로 신경질환, 특히 파킨슨병과 근긴장이상증 치료에 사용됩니다. 파킨슨병에서 DBS는 떨림, 경직, 서맥과 같은 운동 증상을 감소시켜 환자의 삶의 질을 크게 향상시킵니다. DBS는 또한 강박장애(OCD), 간질, 주요우울장애와 같은 질병에 대한 연구도 진행되고 있으며, 그 치료 가능성은 더욱 높아지고 있습니다.
뇌심부자극장치(DBS)의 향후 용도는 간질, 주요우울장애, 강박장애(OCD) 등 보다 광범위한 신경학적, 정신의학적 질환의 치료로 확대될 가능성이 있습니다. 자극 기술을 개선하고 치료 효과를 높이는 뇌 활동에 실시간으로 반응하는 적응형 DBS 시스템을 개발하기 위한 연구가 진행 중입니다. 또한, 신경영상과 맞춤의료의 발전으로 환자의 치료 결과를 개선하고 기존 DBS 치료의 부작용을 줄일 수 있는 맞춤형 자극 프로토콜이 가능해질 수 있습니다.
세계의 뇌심부 자극 기기 시장을 형성하고 있는 주요 시장 역학은 다음과 같습니다.
주요 시장 성장 촉진요인
신경질환의 유병률 증가: 파킨슨병, 간질, 근긴장이상증과 같은 신경질환의 유병률 증가는 DBS 장비에 대한 수요를 촉진하고 있습니다. 인구 고령화에 따라 이들 질환의 유병률은 증가할 것으로 예상되며, 효과적인 대체 치료법에 대한 수요가 증가하고 있으며, DBS는 증상 치료와 환자의 삶의 질 향상에 도움이 되는 것으로 나타나 시장 확대에 기여하고 있습니다.
기술의 진보: 보다 복잡한 장치와 정교한 자극 방법의 개발 등 DBS 기술의 혁신으로 치료의 효과와 안전성이 향상되고 있습니다. 뇌의 활동에 따라 실시간으로 자극을 변경할 수 있는 적응형 DBS 장치의 개발은 중요한 성과입니다. 이러한 기술은 환자의 치료 효과를 높이는 동시에 부작용을 최소화하여 DBS를 환자와 의료진 모두에게 보다 바람직한 선택이 될 수 있도록 하고 있습니다.
DBS 치료에 대한 인식과 수용성 증가: DBS 치료의 이점에 대한 의료 전문가와 환자들의 인식이 높아지면서 시장 확대의 원동력이 되고 있습니다. 교육 프로그램 및 옹호 활동으로 치료 과정이 명확해지고, 그 결과 수용도가 높아지고 있습니다. 특히 치료법이 제한적인 경우 약물 치료의 대안을 찾는 환자가 증가함에 따라 DBS 장비에 대한 수요가 증가하여 시장 성장을 가속할 것입니다.
주요 과제
높은 치료비: 주요 과제 중 하나는 DBS 치료의 높은 비용입니다. 많은 환자들이 기기 구입뿐만 아니라 수술 설치 및 지속적인 후속 치료도 받지 못할 수 있습니다. 이 큰 경제적 장벽은 특히 의료 자원이 제한된 신흥 국가에서 DBS에 대한 접근을 제한하는 경우가 많으며, DBS에 대한 보험 적용 범위가 다양하고 환자가 상환을 받기 어렵기 때문에 치료에 대한 접근이 제한될 수 있습니다.
규제상의 장애물: DBS 기기의 규제 승인 절차는 길고 복잡합니다. 제조업체는 엄격한 규정을 준수하고 안전성과 유효성을 입증하기 위해 철저한 임상시험을 실시해야 합니다. 따라서 제품 출시가 지연되거나 개발 비용이 증가할 수 있습니다. 또한, 국가별로 다양한 규제 규범이 존재하기 때문에 더욱 복잡해지고, 기업은 제품을 국제적으로 판매하는 데 어려움을 겪을 수 있습니다.
임상적 한계와 위험: DBS는 일부 질환에 효과가 있는 것으로 나타났지만, 적절한 환자 부족과 수술에 따른 위험 가능성으로 인해 그 사용은 제한적입니다. 모든 환자가 DBS에 잘 반응하는 것은 아니며, 감염, 기기 오작동, 신경학적 문제 등의 부작용이 발생할 수 있습니다. 이러한 임상적 제약은 환자와 의료 전문가가 DBS를 치료 옵션으로 사용하는 것을 꺼리게 하여 시장 성장에 영향을 미칠 수 있습니다.
주요 동향
기술의 진보: 가장 주목할 만한 동향 중 하나는 DBS 기술의 급속한 발전입니다. 실시간 뇌 활동에 자극을 적용하는 폐쇄 루프 시스템이 보편화되고 있습니다. 이러한 장치는 환자의 고유한 요구에 맞는 정확한 전기 자극을 공급하여 치료를 최적화하고 부작용을 최소화하면서 치료 결과를 개선할 수 있습니다. 또한, 전극 설계와 재료의 발전으로 DBS 장치의 효과와 내구성이 향상되고 있습니다.
또 다른 주요 개발은 DBS의 적용 범위가 전형적인 이용 사례를 넘어서는 것으로, DBS는 주로 파킨슨병과 근긴장이상증 치료에 사용되어 왔지만, 연구자들은 간질, 강박장애(OCD), 주요우울장애 등 다양한 신경질환과 정신질환의 치료 가능성도 조사했습니다. 연구하고 있습니다. 이러한 폭이 넓어짐에 따라 수요가 확대되고 시장 성장의 새로운 기회를 창출하고 있습니다.
인식과 수용성 증가: 잠재적 치료 옵션으로서 DBS에 대한 지식이 증가함에 따라 시장 성장의 원동력이 되고 있습니다. 교육 활동과 옹호 단체들이 DBS의 이점을 홍보하면서 의료 전문가와 환자들 사이에서 DBS에 대한 수용성이 높아지고 있습니다. 이러한 추세는 다양한 장애에 대한 안전하고 효과적인 치료법으로 DBS에 대한 신뢰를 촉진하는 우수한 임상 결과와 환자들의 증언에 의해 뒷받침되고 있습니다.
Deep Brain Stimulation Devices Market size was valued at USD 1.46 Billion in 2023 and is projected to reach USD 2.77 Billion by 2032, growing at a CAGR of 9.20% from 2026 to 2032.
Deep Brain Stimulation Devices (DBS) are medical devices that send electrical impulses to specific brain regions via implanted electrodes. These devices are linked to a pulse generator which is normally inserted beneath the skin in the chest region. DBS is generally used to control aberrant brain activity which has therapeutic benefits for a variety of neurological diseases.
They are generally used to treat neurological illnesses, specifically Parkinson's disease and dystonia. In Parkinson's disease, DBS reduces motor symptoms such as tremors, stiffness, and bradykinesia, considerably increasing patients' quality of life. DBS can aid with dystonia by reducing involuntary muscle contractions allowing for more movement control. DBS is also being investigated for illnesses such as obsessive-compulsive disorder (OCD), epilepsy, and major depressive disorder, which increases its therapeutic potential.
The future uses of Deep Brain Stimulation Devices (DBS) may expand to treat a wider range of neurological and psychiatric disorders such as epilepsy, major depressive disorder, and obsessive-compulsive disorder (OCD). Research is ongoing to refine stimulation techniques and develop adaptive DBS systems that respond in real-time to brain activity enhancing treatment efficacy. Additionally, advancements in neuroimaging and personalized medicine could enable tailored stimulation protocols improving outcomes for patients and reducing side effects associated with traditional DBS therapies.
The key market dynamics that are shaping the global Deep Brain Stimulation Devices Market include:
Key Market Drivers:
Increasing Prevalence of Neurological Disorders: The increased prevalence of neurological diseases such as Parkinson's disease, epilepsy, and dystonia has fuelled demand for DBS devices. As populations age, the prevalence of these illnesses is predicted to rise, creating a higher demand for effective treatment alternatives. DBS has been shown helpful in treating symptoms and enhancing patients' quality of life, resulting in market expansion.
Technological Advancements: DBS technology innovations, such as the creation of more complex devices and refined stimulation procedures, are improving the treatment's effectiveness and safety. The development of adaptive DBS devices that can modify stimulation in real-time based on brain activity is a significant achievement. These technologies increase patient results while minimising negative effects, making DBS a more desirable option for both patients and healthcare providers.
Growing Awareness and Acceptance of DBS Therapy: Increased awareness among healthcare professionals and patients about the benefits of DBS therapy helps to drive market expansion. Educational programs and advocacy efforts are helping to demystify the treatment process, resulting in more acceptance. As more patients seek alternatives to medication, particularly when treatment is limited, demand for DBS devices rises, promoting market growth.
Key Challenges:
High Cost of Treatment: One of the main challenges is the high expense of DBS therapy. Many patients may be unable to afford the gadgets as well as surgical installation and continuing follow-up care. This significant financial barrier frequently restricts access to DBS, especially in developing countries where healthcare resources are limited. Insurance coverage for DBS varies, and patients may have difficulty receiving reimbursement restricting treatment access.
Regulatory Hurdles: The regulatory licensing process for DBS devices can be lengthy and complicated. Manufacturers must follow strict rules and conduct thorough clinical trials to demonstrate safety and efficacy. This might lead to delayed product introductions and higher development expenditures. Furthermore, various regulatory norms across countries add another layer of complexity making it difficult for companies to market their products internationally
Clinical Limitations and Risks: While DBS has shown beneficial for some illnesses, its use is limited because of a lack of appropriate patients and the possible hazards involved with surgery. Not all patients respond well to DBS, and some may develop side effects including infection, device malfunction, or neurological problems. These clinical constraints may dissuade patients and healthcare professionals from using DBS as a therapeutic option affecting market growth.
Key Trends:
Technological Advancements: One of the most noteworthy trends is the rapid development of DBS technology. Closed-loop systems which adapt stimulation to real-time brain activity, are becoming more common. These devices can optimize treatment by delivering precise electrical impulses suited to the patient's specific needs, potentially boosting outcomes while minimising negative effects. Furthermore, advances in electrode design and materials improve the efficacy and durability of DBS devices.
Increasing Applications: Another key development is the growth of DBS applications beyond their typical use cases. While DBS has predominantly been used to treat Parkinson's disease and dystonia, researchers are also investigating its potential for treating various neurological and psychiatric diseases such as epilepsy, obsessive-compulsive disorder (OCD), and major depressive disorder. This expanded breadth is increasing demand and creating new opportunities for market growth.
Growing Awareness and Acceptance: Increased knowledge of DBS as a potential treatment option is also driving market growth. Educational activities and advocacy groups are publicising the benefits of DBS, resulting in increased acceptability among healthcare professionals and patients. This trend is supported by excellent clinical outcomes and patient testimonials that promote faith in DBS as a safe and effective treatment for a variety of disorders
Here is a more detailed regional analysis of the global Deep Brain Stimulation Devices Market:
North America:
North America dominates the deep brain stimulation (DBS) devices market due to its advanced healthcare infrastructure and strong expenditure in R&D. The presence of significant medical equipment manufacturers and cutting-edge technological advancements helps to accelerate the development of sophisticated DBS systems. Furthermore, the region has a strong regulatory structure that facilitates the approval and commercialization of medical devices enabling the availability of high-quality treatment choices for individuals with neurological illnesses.
Furthermore, the rising prevalence of disorders including Parkinson's disease, epilepsy, and depression in North America increases demand for DBS therapy. Growing awareness among healthcare professionals and patients about the usefulness of DBS in controlling various illnesses helps to drive market expansion. Collaboration among healthcare providers, researchers, and manufacturers creates a favorable climate for clinical trials and product introductions reinforcing North America's dominant position in the worldwide DBS device industry.
Asia-Pacific:
Asia Pacific is the fastest-growing region in the deep brain stimulation (DBS) devices market, owing to several factors including the rising prevalence of neurological illnesses such as Parkinson's disease, epilepsy, and depression. As the population ages, the prevalence of these disorders rises generating the need for effective treatments such as DBS. Furthermore, improved healthcare infrastructure in countries such as China and India increases access to innovative medical technologies which drives market growth.
Furthermore, the region is seeing tremendous investment in R&D, which is driving advancements in DBS technology. Governments and the commercial sector are working to promote neuromodulation medicines which are critical to improving patient outcomes. Increased awareness of DBS among healthcare professionals and patients combined with favorable reimbursement regulations is also helping to drive the market in Asia Pacific. This combination of increased demand, technological developments, and supporting healthcare regulations places Asia Pacific as a market leader for DBS devices.
The Deep Brain Stimulation Devices Market is segmented based on Product Type, Application, End-User, and Geography.
Based on the Product Type, the Global Deep Brain Stimulation Devices Market is bifurcated into Single-channel Deep Brain Stimulator and Dual-channel Deep Brain Stimulator. The dual-channel deep brain stimulator is more dominant in the Deep Brain Stimulation Devices Market. This dominance stems from its ability to target multiple brain regions simultaneously offering more effective treatment for complex neurological conditions. By allowing for independent programming of each channel, dual-channel stimulators enhance therapeutic outcomes and provide greater customization for patient needs. This versatility and improved efficacy make dual-channel devices the preferred choice among healthcare providers contributing to their increased market share over single-channel stimulators.
Based on Application, the Global Deep Brain Stimulation Devices Market is bifurcated into Parkinson's Disease, Essential Tremor, Dystonia, Epilepsy, and Others. In the Deep Brain Stimulation (DBS) Devices market, Parkinson's Disease is the most dominant indication. The significant prevalence of Parkinson's disease, along with its challenging motor symptoms such as tremors and rigidity, drives the demand for DBS as an effective treatment option. Additionally, the established efficacy of DBS in alleviating symptoms of Parkinson's enhances its adoption among healthcare providers. While other conditions like Essential Tremor and Dystonia also contribute to the market, Parkinson's remains the leading focus for DBS applications.
Based on the End-User, the Global Deep Brain Stimulation Devices Market is bifurcated into Hospitals, Ambulatory Surgical Centers, Neurological Clinics, and Others. Hospitals are the most dominant segment in the Deep Brain Stimulation Devices Market. They offer comprehensive neurological care, including specialized surgical procedures and post-operative support for patients undergoing deep brain stimulation. The presence of advanced medical facilities and experienced healthcare professionals in hospitals ensures proper device implantation and patient management. Additionally, hospitals are often involved in clinical trials and research contributing to advancements in DBS technology and treatment protocols which further solidifies their leading position in the market.
Based on Geography, the Global Deep Brain Stimulation Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is more dominant in the deep brain stimulation (DBS) devices market due to advanced healthcare infrastructure, significant investment in research and development, and a high prevalence of neurological disorders such as Parkinson's disease and epilepsy. The presence of key market players and innovative technologies in the region fosters rapid advancements in DBS solutions. Additionally, favorable reimbursement policies and increasing awareness of DBS therapies among healthcare professionals and patients contribute to the growing adoption of these devices in North America.
The "Global Deep Brain Stimulation Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, LivaNova PLC, Aleva NeuroTechnologies, Beijing PINS Medical Co., Ltd, SceneRay Co Ltd., and Michigan Tech Researchers.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.